These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33119791)

  • 1. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
    Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
    Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.
    Cagliari M; Bressi B; Bassi MC; Fugazzaro S; Prati G; Iotti C; Costi S
    Phys Ther; 2022 Mar; 102(3):. PubMed ID: 34972863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
    Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
    Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Bolam KA; Taaffe DR
    Med Sci Sports Exerc; 2019 Apr; 51(4):607-614. PubMed ID: 30395051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
    Joseph JS; Lam V; Patel MI
    Eur Urol Oncol; 2019 Sep; 2(5):551-561. PubMed ID: 31411986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy.
    Dalla Via J; Daly RM; Owen PJ; Mundell NL; Rantalainen T; Fraser SF
    Bone; 2019 Oct; 127():367-375. PubMed ID: 31189088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
    Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
    Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.
    Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU
    BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Jones C; Gray S; Brown M; Brown J; McCloskey E; Rai BP; Clarke N; Sachdeva A
    Eur Urol Oncol; 2024 Oct; 7(5):993-1004. PubMed ID: 38383277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
    Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
    BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.
    Alibhai SM; Mohamedali HZ; Gulamhusein H; Panju AH; Breunis H; Timilshina N; Fleshner N; Krahn MD; Naglie G; Tannock IF; Tomlinson G; Warde P; Duff Canning S; Cheung AM
    Osteoporos Int; 2013 Oct; 24(10):2571-9. PubMed ID: 23563932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musculoskeletal Responses to Exercise Plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-Month RCT.
    Dalla Via J; Owen PJ; Daly RM; Mundell NL; Livingston PM; Rantalainen T; Foulkes SJ; Millar JL; Murphy DG; Fraser SF
    Med Sci Sports Exerc; 2021 Oct; 53(10):2054-2065. PubMed ID: 33867499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.
    Shao W; Zhang H; Qi H; Zhang Y
    PLoS One; 2022; 17(2):e0263918. PubMed ID: 35167609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.